SCHEMBL286794

SCHEMBL286794

O=C(O)c1cccc2c1C=CC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 4/20 0.41
TSHR P16473 2/20 0.38
NR4A1 P22736 1/20 0.38
NR4A2 P43354 1/20 0.38
NR4A3 Q92570 1/20 0.38
KDM4E B2RXH2 4/20 0.38
HPGD P15428 4/20 0.38
HMGB1 P09429 2/20 0.38
NAPRT Q6XQN6 2/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
CA7 P43166 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL36891321 1.00 ALDH1A1 (0.43) ALDH1A1ALOX15HSD17B10TSHRNR4A1
SCHEMBL6201130 0.87 ALDH1A1 (0.39) ALDH1A1ALOX15HSD17B10TSHRNR4A1
SCHEMBL13980589 0.83 ALDH1A1 (0.42) ALDH1A1ALOX15KDM4EHPGDCA1
SCHEMBL16116287 0.83 PARP1 (0.46) ALDH1A1HSD17B10TSHRKDM4EHPGD
SCHEMBL29354955 0.83 PARP1 (0.46) ALDH1A1HSD17B10TSHRKDM4EHPGD
SCHEMBL5753321 0.81 ALDH1A1 (0.40) ALDH1A1ALOX15HSD17B10TSHRNR4A1
Hydrochloric Acid SCHEMBL20510158 0.81 PARP1 (0.45) ALDH1A1HSD17B10TSHRKDM4EHPGD
SCHEMBL9365693 0.80 HSD17B10 (0.46) ALDH1A1HSD17B10TSHRNR4A1NR4A2
SCHEMBL5749754 0.79 ALDH1A1 (0.38) ALDH1A1ALOX15HSD17B10TSHRNR4A1
SCHEMBL8765423 0.79 TRPA1 (0.50) ALDH1A1ALOX15HSD17B10TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019200114-A1 METHODS FOR PREPARING SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDE COMPOUNDS ARBUTUS BIOPHARMA CORPORATION (CA) 2019-10-17 WO claimed
CN-110267944-A Compounds useful for treating gastrointestinal disorders 阿德利克斯股份有限公司 2019-09-20 CN claimed
CN-105209429-B SHIP1 conditioning agents and relative method 阿奎诺克斯药物(加拿大)公司 2018-05-29 CN claimed
US-11774853-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-10-03 US disclosed
US-11415887-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-08-16 US disclosed
US-11187980-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-11-30 US disclosed
US-20210302838-A1 RESIST COMPOSITION AND PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-09-30 US disclosed
US-20200272048-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-08-27 US disclosed
US-20200241414-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-07-30 US disclosed
US-20200192222-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-06-18 US disclosed
US-20200073237-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-03-05 US disclosed
CN-106459019-A Azoline compounds 巴斯夫欧洲公司 2017-02-22 CN disclosed
US-9360753-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-06-07 US disclosed
US-9164383-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-10-20 US disclosed
WO-2014170915-A1 INSECT REPELLENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2014-10-23 WO disclosed
US-20130029270-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-01-31 US disclosed
US-20120202153-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-08-09 US disclosed
US-20120202153-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-08-09 US disclosed
EP-2427444-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL Merck Sharp & Dohme Corp. (US) 2012-03-14 EP disclosed
WO-2010121646-A1 HETEROCYCLIC COMPOUNDS AS MEK INHIBITORS NOVARTIS AG (CH) 2010-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200241414-A1 RESIST COMPOSITION AND PATTERNING PROCESS INSR, HNRNPU, HNRNPR ALDH1A1 4836/4885ALOX15 1714/4885HSD17B10 3986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.